USPTO 2015–2025 USPTO PatentsView US Corporation

Focal Therapeutics Inc.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Focal ranks #31,666 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#31,666
of 49,997 US assignees by volume
22nd percentile
by Innovation Score (26.8/100)
16.5
avg claims per patent
-86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31666 · US Corporation #31,666 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 8 grants
  • MID-PACK #31,666/49,997
  • PHOTO-FINISH FLY CAT Electrical
  • CPC-NARROW A61B · 7 areas
  • INNOV-THIN 26.8/100
  • CLAIMS-RICH 16.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -86% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: FLY CAT Electrical Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Focal

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Focal's Innovation Score is 26.8/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Focal's grants concentrate

Focal Therapeutics Inc. is a focused PatentsView assignee: 7 CPC subclasses with 87.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Focal sits between FLY CAT Electrical Co., Ltd. and Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico.

Who files at Focal's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Focal holds 8 patents at rank #31,632, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Focal

By rank, the assignees closest to #31,632 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Focal's primary technology class.

Focal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152017201820192020 1
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Focal Therapeutics Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 25.0%
2017 1 12.5%
2018 1 12.5%
2019 3 37.5%
2020 1 12.5%

Where it ranks

Overall rank by patents

#31,666

of 49,997 tracked assignees

Innovation Score

26.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Focal Therapeutics Inc.'s patent record in context - here's where to go next.

  • Focal Therapeutics Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 87.5% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #31,666 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Focal Therapeutics Inc. against FLY CAT Electrical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.